Jeonjinbio Co., Ltd. (KOSDAQ: 110020)

Jeonjinbio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21,696	60,093	25,582	34,243	66,160	31,749
Market Cap Growth	-6.65%	134.91%	-25.29%	-48.24%	108.39%	-27.01%
Enterprise Value	15,975	63,882	28,671	29,482	70,217	31,107
Last Close Price	2395.00	8030.00	3740.00	5400.00	10950.00	6084.11
PS Ratio	0.98	3.83	3.28	10.65	17.11	8.04
PB Ratio	1.29	9.66	2.67	3.17	5.86	10.95
P/TBV Ratio	2.06	9.77	2.70	3.19	5.90	11.17
EV/Sales Ratio	0.83	4.07	3.68	9.17	18.16	7.88
EV/EBITDA Ratio	7.67	108.19	-	-	-	-
Debt / Equity Ratio	0.03	0.90	0.62	0.69	0.46	0.94
Debt / EBITDA Ratio	0.27	9.48	-	-	-	-
Debt / FCF Ratio	0.86	-	-	-	-	-
Asset Turnover	1.02	0.88	0.36	0.15	0.31	0.58
Inventory Turnover	6.20	5.83	4.52	4.02	5.04	3.91
Quick Ratio	2.48	0.40	0.26	1.11	1.24	6.37
Current Ratio	3.59	0.69	0.60	1.16	1.36	6.91
Return on Equity (ROE)	-1.58%	-81.59%	-30.58%	-19.10%	-48.21%	-42.96%
Return on Assets (ROA)	1.24%	-4.37%	-9.17%	-8.70%	-9.31%	-18.09%
Return on Capital (ROIC)	1.46%	-5.69%	-11.62%	-10.94%	-10.60%	-20.82%
Earnings Yield	-1.08%	-10.72%	-12.17%	-6.16%	-5.17%	-4.61%
FCF Yield	2.99%	-1.60%	-22.30%	-12.36%	-12.26%	-6.30%
Buyback Yield / Dilution	-12.00%	-10.68%	-6.14%	-27.16%	-2.69%	-12.46%
Total Shareholder Return	-12.00%	-10.68%	-6.14%	-27.16%	-2.69%	-12.46%

Source: S&P Capital IQ. Standard template. Financial Sources.